Objective – To compare the adrenocortical response of healthy dogs to a commonly used dose of a nonadsorbed tetracosactide product (tetracosactide) with responses to 2 doses of a depot formulation of tetracosactide (depot tetracosactide) Animals – 14 dogs Procedures – Dogs were randomly assigned to receive tetracosactide (5 mg/kg, IV) or depot tetracosactide (250 µg, IM, ore 5 µg/kf, IM). Dogs received each treatment once with a 2-week interval between treatments. Blood samples were assayed for cortisol, progesterone, 17-hydroxyprogesterone, androstenedione, and estradiol concentrations. Results – Serum cortisol concentrations were significantly higher than the preadministration (baseline) concentrations for all treatments 60 minutes aft...
It is recommended that trilostane therapy of canine hyperadrenocorticism is monitored using an ACTH ...
Abstract Background The ideal method for monitoring trilostane therapy in dogs with hypercortisolism...
INTRODUCTION Trilostane therapy, the treatment of choice for pituitary- dependent hyperadrenocortici...
BACKGROUND The ACTH stimulation test is used to evaluate the adrenocortical reserve. Recently, the ...
BACKGROUND: The effectiveness of trilostane treatment is currently monitored by regular ACTH stimula...
Background: The use of adrenocorticotropic hormone stimulation test as method to monitor efficacy of...
Background: The use of adrenocorticotropic hormone stimulation test as method to monitor efficacy of...
Background: The use of adrenocorticotropic hormone stimulation test as method to monitor efficacy of...
There is limited information regarding the value of constitutive components of the ACTH stimulation ...
BackgroundStandard protocols for adrenocorticotropic hormone (ACTH) stimulation testing (ACTHst) oft...
BackgroundResults of ACTH stimulation test (ACTHst), pre- and post-trilostane serum cortisol concent...
The serum concentrations of cortisol and cortisone were measured in 19 healthy dogs and in 13 dogs w...
BackgroundStandard protocols for adrenocorticotropic hormone (ACTH) stimulation testing (ACTHst) oft...
BackgroundTrilostane medical treatment of naturally occurring hyperadrenocorticism (NOH) in dogs is ...
BACKGROUND The adrenocorticotropic hormone (ACTH) stimulation test is the gold standard for diagnos...
It is recommended that trilostane therapy of canine hyperadrenocorticism is monitored using an ACTH ...
Abstract Background The ideal method for monitoring trilostane therapy in dogs with hypercortisolism...
INTRODUCTION Trilostane therapy, the treatment of choice for pituitary- dependent hyperadrenocortici...
BACKGROUND The ACTH stimulation test is used to evaluate the adrenocortical reserve. Recently, the ...
BACKGROUND: The effectiveness of trilostane treatment is currently monitored by regular ACTH stimula...
Background: The use of adrenocorticotropic hormone stimulation test as method to monitor efficacy of...
Background: The use of adrenocorticotropic hormone stimulation test as method to monitor efficacy of...
Background: The use of adrenocorticotropic hormone stimulation test as method to monitor efficacy of...
There is limited information regarding the value of constitutive components of the ACTH stimulation ...
BackgroundStandard protocols for adrenocorticotropic hormone (ACTH) stimulation testing (ACTHst) oft...
BackgroundResults of ACTH stimulation test (ACTHst), pre- and post-trilostane serum cortisol concent...
The serum concentrations of cortisol and cortisone were measured in 19 healthy dogs and in 13 dogs w...
BackgroundStandard protocols for adrenocorticotropic hormone (ACTH) stimulation testing (ACTHst) oft...
BackgroundTrilostane medical treatment of naturally occurring hyperadrenocorticism (NOH) in dogs is ...
BACKGROUND The adrenocorticotropic hormone (ACTH) stimulation test is the gold standard for diagnos...
It is recommended that trilostane therapy of canine hyperadrenocorticism is monitored using an ACTH ...
Abstract Background The ideal method for monitoring trilostane therapy in dogs with hypercortisolism...
INTRODUCTION Trilostane therapy, the treatment of choice for pituitary- dependent hyperadrenocortici...